Rhumbline Advisers Relay Therapeutics, Inc. Transaction History

Rhumbline Advisers

$109 Billion
Q3 2024

A detailed history of Rhumbline Advisers transactions in Relay Therapeutics, Inc. stock. As of the latest transaction made, Rhumbline Advisers holds 157,912 shares of RLAY stock, worth $656,913. This represents 0.0% of its overall portfolio holdings.

Number of Shares

157,912

Previous 163,895 3.65%

Holding current value

$656,913

Previous $1.07 Million 4.68%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$6.23 - $9.51 $37,274 - $56,898	-5,983 Reduced 3.65%	157,912 $1.12 Million
Q2 2024 Aug 01, 2024	BUY	$5.9 - $8.02 $44,297 - $60,214	7,508 Added 4.8%	163,895 $1.07 Million
Q1 2024 May 09, 2024	BUY	$7.5 - $12.07 $37,065 - $59,649	4,942 Added 3.26%	156,387 $1.3 Million
Q4 2023 Feb 08, 2024	SELL	$6.01 - $11.48 $10,409 - $19,883	-1,732 Reduced 1.13%	151,445 $1.67 Million
Q3 2023 Nov 09, 2023	BUY	$8.24 - $12.97 $39,313 - $61,879	4,771 Added 3.21%	153,177 $1.29 Million
Q2 2023 Aug 08, 2023	BUY	$9.99 - $18.27 $128,331 - $234,696	12,846 Added 9.48%	148,406 $1.86 Million
Q1 2023 May 11, 2023	BUY	$15.0 - $22.76 $100,440 - $152,400	6,696 Added 5.2%	135,560 $2.23 Million
Q4 2022 Feb 14, 2023	BUY	$14.16 - $24.02 $145,918 - $247,526	10,305 Added 8.69%	128,864 $1.93 Million
Q3 2022 Nov 10, 2022	BUY	$18.07 - $31.37 $146,764 - $254,787	8,122 Added 7.35%	118,559 $2.65 Million
Q2 2022 Aug 11, 2022	BUY	$13.31 - $34.88 $465,836 - $1.22 Million	34,999 Added 46.39%	110,437 $1.85 Million
Q1 2022 May 12, 2022	BUY	$20.26 - $32.36 $110,153 - $175,941	5,437 Added 7.77%	75,438 $2.26 Million
Q4 2021 Feb 10, 2022	BUY	$26.0 - $37.03 $214,760 - $305,867	8,260 Added 13.38%	70,001 $2.15 Million
Q3 2021 Nov 12, 2021	BUY	$29.75 - $37.99 $85,561 - $109,259	2,876 Added 4.89%	61,741 $1.95 Million
Q2 2021 Aug 05, 2021	BUY	$27.5 - $38.19 $236,032 - $327,784	8,583 Added 17.07%	58,865 $2.15 Million
Q1 2021 May 06, 2021	BUY	$32.52 - $61.53 $322,013 - $609,270	9,902 Added 24.52%	50,282 $1.74 Million
Q4 2020 Feb 10, 2021	BUY	$35.51 - $54.03 $133,908 - $203,747	3,771 Added 10.3%	40,380 $1.68 Million
Q3 2020 Nov 12, 2020	BUY	$32.81 - $45.1 $1.2 Million - $1.65 Million	36,609 New	36,609 $1.56 Million

Others Institutions Holding RLAY

# of Institutions

204

Shares Held

156M

Call Options Held

207K

Put Options Held

40K

View Full List

About Relay Therapeutics, Inc.

Ticker RLAY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 120,219,000
Market Cap $500M
Description
Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company's lead product candidates include RLY-4008, an oral small molecule inhib...

More about RLAY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.

Account

Rhumbline Advisers Relay Therapeutics, Inc. Transaction History